SENTINELONE INC -CLASS A (S)

US81730H1095 - Common Stock

24.21  +0.3 (+1.25%)

Premarket: 24.15 -0.06 (-0.25%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to S. S was compared to 278 industry peers in the Software industry. While S has a great health rating, there are worries on its profitability. S is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

S had negative earnings in the past year.
In the past year S had a positive cash flow from operations.
S had negative earnings in each of the past 5 years.
S had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

S's Return On Assets of -12.00% is on the low side compared to the rest of the industry. S is outperformed by 62.95% of its industry peers.
S has a Return On Equity of -17.24%. This is comparable to the rest of the industry: S outperforms 44.60% of its industry peers.
Industry RankSector Rank
ROA -12%
ROE -17.24%
ROIC N/A
ROA(3y)-14.88%
ROA(5y)-27.06%
ROE(3y)-20.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

S's Gross Margin of 73.35% is fine compared to the rest of the industry. S outperforms 61.15% of its industry peers.
S's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for S so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y7.24%
GM growth 5Y3.94%

7

2. Health

2.1 Basic Checks

S does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for S has been increased compared to 1 year ago.
The number of shares outstanding for S has been reduced compared to 5 years ago.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

S has an Altman-Z score of 5.74. This indicates that S is financially healthy and has little risk of bankruptcy at the moment.
S has a better Altman-Z score (5.74) than 65.47% of its industry peers.
S has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.74
ROIC/WACCN/A
WACC11.64%

2.3 Liquidity

S has a Current Ratio of 1.74. This is a normal value and indicates that S is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.74, S perfoms like the industry average, outperforming 52.52% of the companies in the same industry.
A Quick Ratio of 1.74 indicates that S should not have too much problems paying its short term obligations.
S has a Quick ratio (1.74) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 1.74

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.44% over the past year.
S shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.12%.
S shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -54.66% yearly.
EPS 1Y (TTM)97.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)47.12%
Revenue growth 3Y88.26%
Revenue growth 5Y-54.66%
Sales Q2Q%28.32%

3.2 Future

Based on estimates for the next years, S will show a very strong growth in Earnings Per Share. The EPS will grow by 44.49% on average per year.
S is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 28.52% yearly.
EPS Next Y112.8%
EPS Next 2Y65.13%
EPS Next 3Y50.02%
EPS Next 5Y44.49%
Revenue Next Year32.33%
Revenue Next 2Y29.25%
Revenue Next 3Y27.28%
Revenue Next 5Y28.52%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

S reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 118.97, the valuation of S can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as S.
S is valuated expensively when we compare the Price/Forward Earnings ratio to 23.53, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 118.97

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

S's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as S's earnings are expected to grow with 50.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.13%
EPS Next 3Y50.02%

0

5. Dividend

5.1 Amount

S does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SENTINELONE INC -CLASS A

NYSE:S (12/16/2024, 8:04:01 PM)

Premarket: 24.15 -0.06 (-0.25%)

24.21

+0.3 (+1.25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.78B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 118.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12%
ROE -17.24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 73.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.74
Quick Ratio 1.74
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)97.44%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y112.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)47.12%
Revenue growth 3Y88.26%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y